Advaxia Biologics
Pomezia, Italy advaxia.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
Advaxia Biologics is a contract development and manufacturing organization focused on adenovirus-based vaccines and other biotherapeutics. It provides integrated development, analytical, quality, regulatory, and cGMP manufacturing services for pharmaceutical and biotech clients. The company operates at its facility in Pomezia, near Rome, Italy.
Services
Expression Systems
Develops and optimizes mammalian expression systems and generates pre-GMP materials such as cell lines and virus seed stocks.
Process Development
Translates adenovirus research into reproducible manufacturing processes and develops upstream and downstream production steps.
Analytical Development
Develops, qualifies, and validates assays for product characterization, safety testing, impurities, potency, and cell and molecular biology.
cGMP Manufacturing
Manufactures adenovirus vaccine products under cGMP conditions, including cell banks, virus banks, clinical batches, and fill-finish.
CDMO: development & manufacturing
Quality Control
Performs in-process control and finished product testing for potency, purity, identity, impurities, and other product attributes.
Identity Testing
Verifies genetic identity and integrity of adenovirus products using PCR, DNA sequencing, and restriction enzyme mapping.
Quality Assurance
Provides quality assurance support across project workflows and helps streamline QA processes.
Regulatory Support
Provides CMC support for clinical regulatory activities, including drafting and clinical filing.
Capabilities
- Assays and studies
- Process development
- Analytical development
- Fill-finish
- Mammalian expression
- PCR
- qPCR
13 more
- SDS-PAGE
- ELISA
- LAL
- Spectrophotometry (UV/visible)
- Electrophoresis
- Immuno-staining assays
- Restriction analysis
- Western blot analysis
- Mycoplasma testing
- Cell-based assays
- In vitro potency assays
- Genome quantification
- DNA sequencing
- Scale and capacity
- Up to 250L scale size in single-use stirred bioreactor
- Up to 1,000 vials per batch
- Up to 2,700 vials per hour
- Therapeutic areas
- Infectious diseases
- Oncology
- Vaccines
Instruments and platforms
- Flexicon
- NGS technology
Modalities and species
- Modalities
- Antibody
- Viral vector
- Vaccine
- Species and models
- Mammalian cells
- Adherent cell lines
- Suspension cell lines
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Details
- Type
- CDMO
- Based in
- Pomezia, Italy
- Sites
- Rome, Italy
- Serves
- United States, Europe, Asia, Canada